Perceptions and patient care needs among hepatitis B patients during COVID-19.

COVID-19 HBV Hepatitis B virus Patients Prevention Racial and ethnic minorities Resources

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
30 Jun 2022
Historique:
received: 13 12 2021
accepted: 03 06 2022
entrez: 30 6 2022
pubmed: 1 7 2022
medline: 6 7 2022
Statut: epublish

Résumé

The novel coronavirus of 2019 (COVID-19) has been and continues to be a rapidly developing public health crisis, that has also disrupted routine and maintenance health care for people living with chronic conditions. Some of these chronic conditions also put individuals at increased risk of COVID-19 complications, particularly if the condition is not under control. For these reasons, the exploratory study reported here examined the needs and preparedness of patients at a community health organization that specifically provides hepatitis B virus (HBV) care for high-risk groups that had previously tested positive for HBV. Current study utilized exploratory analysis of qualitative COVID-19-related statements collected during calls to a total of 44 patients reached during April and May, 2020 in the Washington D.C. area. Researchers worked with a community based non-profit organization to reach current HBV + and HCV + patients to provide retention in care and assess patient needs in maintaining management of their condition adapted to include offering medication refills, telehealth, and other resources. We gathered emergent themes, using socio-ecological framework, regarding capacity and needs for managing their chronic condition in a vulnerable population during the initial, most interrupted, time period of a global public health crisis. From the notes of the calls, five thematic categories emerged: COVID-19 prevention awareness, assistance program access, medical resource access, access to knowledge and awareness about assistance programs, and needs and barriers. From these five themes, providers can develop strategies to better prepare their patients and provide care to patients with chronic conditions during major disruptions. Future recommendations include increasing hepatitis and COVID-19 vaccine efforts, collaborating with community partners, and screening and understanding social determinants of health that affect racial and ethnic minorities.

Sections du résumé

BACKGROUND BACKGROUND
The novel coronavirus of 2019 (COVID-19) has been and continues to be a rapidly developing public health crisis, that has also disrupted routine and maintenance health care for people living with chronic conditions. Some of these chronic conditions also put individuals at increased risk of COVID-19 complications, particularly if the condition is not under control. For these reasons, the exploratory study reported here examined the needs and preparedness of patients at a community health organization that specifically provides hepatitis B virus (HBV) care for high-risk groups that had previously tested positive for HBV.
METHODS METHODS
Current study utilized exploratory analysis of qualitative COVID-19-related statements collected during calls to a total of 44 patients reached during April and May, 2020 in the Washington D.C. area. Researchers worked with a community based non-profit organization to reach current HBV + and HCV + patients to provide retention in care and assess patient needs in maintaining management of their condition adapted to include offering medication refills, telehealth, and other resources. We gathered emergent themes, using socio-ecological framework, regarding capacity and needs for managing their chronic condition in a vulnerable population during the initial, most interrupted, time period of a global public health crisis.
RESULTS RESULTS
From the notes of the calls, five thematic categories emerged: COVID-19 prevention awareness, assistance program access, medical resource access, access to knowledge and awareness about assistance programs, and needs and barriers. From these five themes, providers can develop strategies to better prepare their patients and provide care to patients with chronic conditions during major disruptions.
CONCLUSIONS CONCLUSIONS
Future recommendations include increasing hepatitis and COVID-19 vaccine efforts, collaborating with community partners, and screening and understanding social determinants of health that affect racial and ethnic minorities.

Identifiants

pubmed: 35773673
doi: 10.1186/s12913-022-08153-5
pii: 10.1186/s12913-022-08153-5
pmc: PMC9246354
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

846

Subventions

Organisme : U.S. Department of Health Office of Minority Health
ID : CPIMP191177
Organisme : U.S. Department of Health Office of Minority Health
ID : CPIMP191177
Organisme : U.S. Department of Health Office of Minority Health
ID : CPIMP191177
Organisme : U.S. Department of Health Office of Minority Health
ID : CPIMP191177
Organisme : U.S. Department of Health Office of Minority Health
ID : CPIMP191177
Organisme : U.S. Department of Health Office of Minority Health
ID : CPIMP191177

Informations de copyright

© 2022. The Author(s).

Références

Ann Intern Med. 2021 Mar;174(3):362-373
pubmed: 33253040
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Health Educ Q. 1988 Winter;15(4):351-77
pubmed: 3068205
BMJ Glob Health. 2021 Jan;6(1):
pubmed: 33402334
J Med Internet Res. 2021 May 19;23(5):e25446
pubmed: 33886489
Am Surg. 2020 Dec;86(12):1615-1622
pubmed: 33231496
Cell. 2021 Aug 19;184(17):4380-4391.e14
pubmed: 34147139
Hepatology. 2021 Feb;73(2):811-820
pubmed: 33150599
Cureus. 2020 Jun 15;12(6):e8645
pubmed: 32550096
ACR Open Rheumatol. 2021 Jun;3(6):381-389
pubmed: 33934576
Physiology (Bethesda). 2020 Sep 1;35(5):288-301
pubmed: 32783610
Prim Care Diabetes. 2021 Feb;15(1):16-17
pubmed: 32535088
J Viral Hepat. 2017 Nov;24(11):1052-1066
pubmed: 28581638
Clin Immunol. 2020 Jun;215:108427
pubmed: 32325252
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257
pubmed: 32915166

Auteurs

Sherrie Flynt Wallington (SF)

School of Nursing, George Washington University, Washington, DC, USA. sflyntwallington@gwu.edu.

Min Jeong Jeon (MJ)

School of Nursing, George Washington University, Washington, DC, USA.

T Angeline Nguyen (TA)

Hepatitis B Initiative of Washington DC, Washington, DC, USA.

Choosonjargal Byambaa (C)

Hepatitis B Initiative of Washington DC, Washington, DC, USA.

Y Tony Yang (YT)

School of Nursing, George Washington University, Washington, DC, USA.

Daisy Le (D)

School of Nursing, George Washington University, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH